Clinical Trial Update: Nicorandil as Anti-inflammatory in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nicorandil as an anti-inflammatory treatment for rheumatoid arthritis is currently recruiting. Sponsor: Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Tanta University | Conditions: Rhumatoid Arthisis | Phase 3 | Status: RECRUITING